Options for the Management of Attention Deficit/Hyperactivity (ADHD)

Marcia L. Buck, Pharm.D., FCCP, FPPAG


Pediatr Pharm. 2011;17(3) 

In This Article

Abstract and Introduction


A wide array of products are currently on the market in the United States for the management of ADHD. Over the past decade, a number of new treatment options have been introduced, including once-daily products, oral liquid and transdermal dosage formulations, and several generic products (Table).[1–14] This issue of Pediatric Pharmacotherapy will provide a brief review of some of these products and highlight their unique properties.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.